Clinical Trials Browser

Phase 1/2 × Interventional × varlilumab × Clear all

NCT03307746 2024-12-02

RiVa

Phase 1/2 Completed

Lymphoma, B-Cell

NCT03617328 2024-02-06

Mel-65

Phase 1/2 Completed

Melanoma